Tag: oral mucositis

November 1, 2018

VIDEO — Life Science Update October 2018

With October behind us, the Investing News Network (INN) has brought together some of the biggest stories in the life...
April 23, 2018

Innovation Pharmaceuticals Signs Drug Supply Contract with Evonik to Bulk Produce Commercial-Grade Brilacidin

Innovation Pharmaceuticals (OTCQB:IPIX) a clinical stage biopharmaceutical company, is pleased to report the Company has signed a drug supply contract...
April 16, 2018

Innovation Pharmaceuticals Data from Phase 2 Brilacidin Oral Mucositis (OM) Trial in Head and Neck Cancer Show Notable Reductions in Median Duration of Severe OM

Innovation Pharmaceuticals (OTCQB:IPIX) a clinical stage biopharmaceutical company, is pleased to report additional information from the Company’s successfully completed Phase...
June 8, 2017

IntelGenx Gets US Patent for Topical Oral Film Technology

IntelGenx announced the US Patent and Trademark Office issued one for the company's topical oral films.
February 21, 2017

Thom Calandra: Investing in Gene-editing Stocks

Thom Calandra is known to investors in the resource space. Recently, he wrote about biotechnology and started his own index...
February 10, 2017

Cellceutix Announces Initiation of Main Clinical Site for Phase 2a Trial of p53 Drug Candidate Kevetrin in the Treatment of Platinum-Resistant/Refractory Ovarian Cancer

BEVERLY, Mass., Feb. 10, 2017 (GLOBE NEWSWIRE) — Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative...
January 17, 2017

Cellceutix Completes Enrollment in Second of Three Planned Cohorts in Phase 2 Clinical Trial of Brilacidin for Inflammatory Bowel Disease

Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and antibiotic applications,...